It was a great week all round, with no big losers at all.
IGG:IG Group posted a good trading update and went up 5%, although I was hoping for a bit more. They are still 19% down but I've had £101 dividends from them and will continue to hold in anticipation of a future re-rate.
PSN:Persimmon went up 7% for the second week in a row, buoyed by lower than expected inflation and the hope mortgage rates will stop rising.
PBX:Probiotix Health went up for the first time since the lock-in period ended. It was only 1p but that was 5% in my main holding and 12% for my recent purchases.
Share of the Week by absolutely miles was OPTI:Optibiotix which went from 7.8p bid price last week to 20.6p this week, a rise of 12.8p. That's more than double! The percentage increase varied between my highest price holding bought for 90p which climbed 14%, to my recent purchases averaging 9.55p which went up 133%.
Here's the ISA and shares portfolio after week 51 of year 8.
| Weekly Change | |||
| Cash | £248.06 | +£10.73 | |
| Portfolio cost | £87,854.54 | +£499.97 | |
| Portfolio sell value (bid price-commission) | £37,083.03 | (-57.8%) | +£14,610.60 |
| Potential profits | £1,248.48 | +£1,095.26 | |
| Yr 8 Dividends | £142.51 | +£10.70 | |
| Yr 8 Interest | £1.79 | +£0 | |
| Yr 8 Profit from sales | -£10,795.53 | +£0 | |
| Yr 8 proj avg monthly profit | -£908.91 | (-18.3%) | +£19.10 |
| Total Dividends | £11,911.43 | +£10.70 | |
| Total Interest | £1.79 | +£0 | |
| Total Profit from sales | £17,298.53 | +£0 | |
| Average monthly cash profit | £301.13 | (6.1%) | -£0.62 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 48% | -1% |
I got a £10 dividend from PLUS:Plus500 and also added £500 which I intended to use to buy PBX:Probiotix Health, but AJ Bell wouldn't let me buy them despite it being ok a few weeks ago. It sounds like lots of people have had trouble buying the shares, so the Aquis exchange is clearly not fit for purpose and these need to be listed on AIM.
Instead I bought another 6,471 shares in JLP:Jubilee Metals at 7.5725p costing £499.97. They promptly dropped to 7.4p. I'm surprised, as they gave a pretty good trading statement this week.
Portfolio value rocketed by £14,610 mainly thanks to OPTI:Optibiotix, but it's still 57% down so there's a long way to go. However, now I've split my OPTI:Optibiotix holding into shares bought at 10p intervals, the holding bought for an average of 15p went £1,065 into profit, and with an increase in GAW:Games Workshop, potential profits rose £1,095.
Almost halved the distance back to the injection line, and no need to lower the Y axis any more.
That's more like it - much higher than the trend line - lets hope we can drag it back up.
Fairly quiet, except for the stonking £17,291 rise in value and my 9.5p OPTI:Optibiotix holding going £1,955 into profit, my 18.2p holding going £17 into profit and my 18.88p holding going £77 into profit, all helping potential profits rise by £2,067.
I reckon that has pretty much halved the distance to the injection line
A glorious sight.
The trading account looks like this after week 365 overall and week 1 of year 8.
What a way to start the new year for this account. Not only do I lose the miserable negative stats suffered from the Year 7 DDDD:4D Pharma collapse, but OPTI:Optibiotix drags the value up by £293 and goes £13 into profit. Surely I won't actually get to sell a share in my trading account?!
It doesn't look as impressive when you see how far it needs to go to get back to the injection line.
Much relief as we go back above the trend line.
Almost halved the distance back to the injection line, and no need to lower the Y axis any more.
That's more like it - much higher than the trend line - lets hope we can drag it back up.
The SIPP looks like this after week 399 overall and week 35 of year 8.
| Weekly Change | ||||
| Cash | £70.70 | +£0 | ||
| Portfolio cost | £96,015.54 | +£0 | ||
| Portfolio sell value (bid price - commission) | £45,399.94 | (-52.7%) | +£17,291.36 | |
| Potential profits | £2,279.20 | +£2,067.76 | ||
| Yr 8 Dividends | £220.93 | +£0 | ||
| Yr 8 Interest | £3.49 | +£0 | ||
| Yr 8 Profit from sales | -£9,597.85 | +£0 | ||
| Yr 8 proj avg monthly profit | -£1,171.40 | (-21.6%) | +£34.45 | |
| Total Dividends | £14,363.71 | +£0 | ||
| Total Interest | £3.74 | +£0 | ||
| Total Profit from sales | £10,835.90 | +£0 | ||
| Average monthly cash profit | £261.94 | (4.8%) | -£0.66 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 37% | +0% |
Fairly quiet, except for the stonking £17,291 rise in value and my 9.5p OPTI:Optibiotix holding going £1,955 into profit, my 18.2p holding going £17 into profit and my 18.88p holding going £77 into profit, all helping potential profits rise by £2,067.
I reckon that has pretty much halved the distance to the injection line
A glorious sight.
The trading account looks like this after week 365 overall and week 1 of year 8.
| Weekly Change | |||
| Cash | £20.26 | +£0 | |
| Portfolio cost | £1,763.50 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,205.84 | (-31.6%) | +£293.78 |
| Potential profits | £13.38 | +£13.38 | |
| Year 8 Dividends | £0 | +£0 | |
| Year 8 Interests | £0 | +£0 | |
| Year 8 Profit | £0 | +£0 | |
| Yr 8 proj avg monthly profit | £0 | (+0%) | +£0 |
| Dividends | £60.10 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£930.69 | +£0 | |
| Average monthly cash profit | -£10.34 | (-7.0%) | +£0.02 |
| (Sold stocks profit + Dividends - Fees / Months) |
What a way to start the new year for this account. Not only do I lose the miserable negative stats suffered from the Year 7 DDDD:4D Pharma collapse, but OPTI:Optibiotix drags the value up by £293 and goes £13 into profit. Surely I won't actually get to sell a share in my trading account?!
It doesn't look as impressive when you see how far it needs to go to get back to the injection line.
Much relief as we go back above the trend line.
I guess there is a risk this week will be a blip and OPTI:Optibiotix will sink again, but I think the market finally recognises that Sweetbiotix is going to happen fairly soon. Launches may be a while off, but companies will need to buy the product long before that, so the key announcements will be around contract signing. One big global contract should see all my losses wiped out. Hope has definitely been re-kindled.
No comments:
Post a Comment